KEY FEATURES
| Full Name | Fibroblast Growth Factor 21 |
|---|---|
| Synonym | FGF-21 |
| Assay Type | Sandwich |
| Reactivity | Mouse |
| Range | 31.25-2000pg/mL |
| Sensitivity | 18.75pg/mL |
| Sample Type | Serum,plasma and other biological fluids |
| Sample Volume | 100μL |
| Detection Wavelength | OD450 |
| Transportation Temperature | 2-8°C |
| Specificity | The kit detected Mouse FGF21 in the samples and no significant cross-species reactions were found |
| Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
| This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Mouse FGF21. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Mouse FGF21 and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Mouse FGF21, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Mouse FGF21. You can calculate the concentration of Mouse FGF21 in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
| Components | Specifications | Storage and Notes |
|---|---|---|
| Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
| Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
| Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
| HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
| Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
| Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
| Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
| Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Mouse FGF21 ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
| Intra-assay Precision | Inter-assay Precision | |||||
|---|---|---|---|---|---|---|
| Sample | 1 | 2 | 3 | 1 | 2 | 3 |
| n | 20 | 20 | 20 | 20 | 20 | 20 |
| Mean (pg/mL) | 91.41 | 215.76 | 684.36 | 90.69 | 228.12 | 665.69 |
| Standard deviation | 5.31 | 10.23 | 29.84 | 4.92 | 9.24 | 34.75 |
| CV(%) | 5.81 | 4.74 | 4.36 | 5.43 | 4.05 | 5.22 |
RECOVERY
The recovery of Mouse FGF21 spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
| Sample Type | Range (%) | Average Recovery (%) |
|---|---|---|
| Serum(n=8) | 89-101 | 96 |
| EDTA plasma (n=8) | 89-103 | 95 |
| Cell culture media (n=8) | 88-99 | 94 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Mouse FGF21 in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with Fgf21 ELISA Kits
| Klb ELISA Kit | publications with Fgf21 and Klb |
| Fgfr1 ELISA Kit | publications with Fgf21 and Fgfr1 |
| Fgfr4 ELISA Kit | publications with Fgf21 and Fgfr4 |
| Fgfr2 ELISA Kit | publications with Fgf21 and Fgfr2 |
| Ppara ELISA Kit | publications with Fgf21 and Ppara |
| Egfr ELISA Kit | publications with Fgf21 and Egfr |
| Cyp7a1 ELISA Kit | publications with Fgf21 and Cyp7a1 |
| Fgfr3 ELISA Kit | publications with Fgf21 and Fgfr3 |
| Igf1r ELISA Kit | publications with Fgf21 and Igf1r |
| Insr ELISA Kit | publications with Fgf21 and Insr |
Pathways associated with Fgf21 ELISA Kit
| ESC Pluripotency Pathways | ESC Pluripotency Pathways |
| Facilitative Na+-independent Glucose Transporters Pathway | Facilitative Na+-independent Glucose Transporters Pathway |
| Glucose Transport Pathway | Glucose Transport Pathway |
| Hexose Transport Pathway | Hexose Transport Pathway |
| MAPK Signaling Pathway | MAPK Signaling Pathway |
| Melanoma Pathway | Melanoma Pathway |
| Metabolism Pathway | Metabolism Pathway |
| Metabolism Of Carbohydrates Pathway | Metabolism Of Carbohydrates Pathway |
Diseases associated with Fgf21 ELISA Kit
| Obesity | publications with Fgf21 and Obesity |
| Insulin Resistance | publications with Fgf21 and Insulin Resistance |
| Fatty Liver | publications with Fgf21 and Fatty Liver |
| Diabetes Mellitus | publications with Fgf21 and Diabetes Mellitus |
| Liver Diseases | publications with Fgf21 and Liver Diseases |
| Inflammation | publications with Fgf21 and Inflammation |
| Cardiovascular Diseases | publications with Fgf21 and Cardiovascular Diseases |
| Disease Models, Animal | publications with Fgf21 and Disease Models, Animal |
| Weight Loss | publications with Fgf21 and Weight Loss |
| Non-alcoholic Fatty Liver Disease | publications with Fgf21 and Non-alcoholic Fatty Liver Disease |
Organs/Tissues associated with Fgf21 ELISA Kit
| Liver | publications with Fgf21 and Liver |
| Pancreas | publications with Fgf21 and Pancreas |
| Testis | publications with Fgf21 and Testis |